You are here: Industry Insights > Shire

News List

Cipla receives final approval for generic version of Shire’s Firazyr expresspharma
July 15, 2020
Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal fiercepharma
May 09, 2019
Takeda is looking to lighten the huge debt burden from the Shire buyout. Novartis wants to beef up its eye medicine portfolio after the Alcon spinoff. Now, the two companies have found a deal where their needs align.
Takeda looking to divest emerging-market assets in wake of Shire acquisition firstwordpharma
January 22, 2019
According to people familiar with the matter, Takeda is mulling a sale of some emerging-market drugs as the company looks to find ways to cut debt after its $62-billion takeover of Shire earlier this month, Bloomberg reported Monday.
Takeda looking to divest emerging-market assets in wake of Shire acquisition firstwordpharma
January 22, 2019
According to people familiar with the matter, Takeda is mulling a sale of some emerging-market drugs as the company looks to find ways to cut debt after its $62-billion takeover of Shire earlier this month, Bloomberg reported Monday.
Takeda’s Shire takeover could herald new era of pharma M&A pharmaphorum
January 10, 2019
Takeda has officially taken over Shire in a deal that could re-establish the trend for mega mergers in big pharma.
Takeda unlikely to sell OTC unit to pay Shire merger debts pharmaphorum
January 08, 2019
Takeda’s $59 billion takeover of Shire is due to close tomorrow (Tuesday) and the company’s CEO Christophe Weber has already given some strong clues about the company’s strategy once the deal completes.
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity fiercepharma
December 19, 2018
Takeda is set to gulp up Shire, whether disgruntled investors like the deal or not. But for those in the latter camp, the biotech’s latest approval may make it easier to swallow.
FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) drugs
December 18, 2018
Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC)....
Rentschler Biopharma to Purchase U.S. Manufacturing Site from Shire americanpharmaceuticalreview
December 18, 2018
Rentschler Biopharma announced the company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA......
Shire purchase backed by Takeda shareholders pharmatimes
December 07, 2018
Takeda announced in May this year a deal to buy the firm, after having its merger proposals previously turned down four times by Shire.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page